What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Genetics, Genome-wide association study, Internal medicine, Cancer and Single-nucleotide polymorphism.
D. Timothy Bishop works mostly in the field of Genome-wide association study, limiting it down to topics relating to Allele and, in certain cases, Genetic linkage.
He has researched Internal medicine in several fields, including Gastroenterology, Surgery and Oncology.
His Single-nucleotide polymorphism research is multidisciplinary, incorporating perspectives in Human genetics and Allele frequency.
His Human genetics research incorporates elements of Polymorphism, Population stratification, Genome, Disease and CDKN2BAS.
His CDKN2A research integrates issues from Hereditary Melanoma, Germline mutation and Melanoma.
His most cited work include:
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (7922 citations)
- Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995)) (1460 citations)
- Genome-wide association study identifies eight loci associated with blood pressure (1026 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Genetics, Internal medicine, Melanoma, Oncology and Genome-wide association study.
His Genetics study is mostly concerned with Single-nucleotide polymorphism, Germline mutation, Gene, CDKN2A and Locus.
His Single-nucleotide polymorphism research is multidisciplinary, incorporating perspectives in Allele and Polymorphism.
His Melanoma study combines topics in areas such as Mutation and Pathology.
His study looks at the relationship between Oncology and topics such as Cohort, which overlap with Cohort study.
His Genome-wide association study research includes elements of Linkage disequilibrium and Genetic association.
He most often published in these fields:
- Genetics (47.03%)
- Internal medicine (37.44%)
- Melanoma (26.94%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (37.44%)
- Oncology (24.66%)
- Colorectal cancer (18.72%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Oncology, Colorectal cancer, Melanoma and Genome-wide association study.
His work on Cancer, Lynch syndrome and Aspirin as part of general Internal medicine research is frequently linked to Mendelian randomization and Dependency, bridging the gap between disciplines.
His biological study spans a wide range of topics, including Odds ratio, Relative risk, Proportional hazards model, Cohort and Candidate gene.
His studies deal with areas such as Epidemiology, Genetic risk, Case-control study, Genotype and Primary tumor as well as Colorectal cancer.
His research in Melanoma intersects with topics in Germline mutation, Disease, Neuroblastoma RAS viral oncogene homolog and Immunotherapy.
D. Timothy Bishop is investigating Genome-wide association study as part of his inquiry into Single-nucleotide polymorphism and Genetics.
Between 2017 and 2021, his most popular works were:
- Discovery of common and rare genetic risk variants for colorectal cancer (131 citations)
- β-Catenin–mediated immune evasion pathway frequently operates in primary cutaneous melanomas (43 citations)
- Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial (32 citations)
In his most recent research, the most cited papers focused on:
Odds ratio, Internal medicine, Oncology, Melanoma and Case-control study are his primary areas of study.
As part of the same scientific family, D. Timothy Bishop usually focuses on Odds ratio, concentrating on Confidence interval and intersecting with Single-nucleotide polymorphism, Breast cancer, Epidemiology of cancer, Mendelian Randomization Analysis and Epidemiology.
His biological study deals with issues like Neuroblastoma RAS viral oncogene homolog, which deal with fields such as Missense mutation, Germline mutation, Hereditary Melanoma, Germline and CDKN2A.
His Missense mutation study introduces a deeper knowledge of Genetics.
He interconnects Genome-wide association study, Cohort study, Colorectal cancer, Family history and Cohort in the investigation of issues within Case-control study.
The Genome-wide association study study combines topics in areas such as Meta-analysis and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
